Archimedes Pharma Limited, the UK based, pan-European specialty pharmaceutical company, announces new positive headline phase III results for NasalFent(R), the Company's innovative and highly differentiated fentanyl citrate nasal spray, developed for ...
Original post: Archimedes Pharma Announces Ground Breaking Phase III Data Showing ... - Medical News Today
- Recent posts
- Walmart pharmacy: Global Pain Management Set To Drive Transdermal ...
- Archimedes Pharma Announces Ground Breaking Phase III Data Showing ... - Medical News Today
- Center for Practical Bioethics sets up $3M pain-care chair - Birmingham Business Journal
- Paradigm Management Services Promotes Thomas Schell to Senior Vice ... - PR Inside
- Spinal Cord Stimulation | Pain Management Physician Brunswick, GA
- Teri Robert - HealthCentral.com
- DJO Incorporated Announces Financial Results for First Quarter 2009 - CNBC
- Chronic Pain Guidelines Suggest Opioids - New York Times
- Experts Recommend Cherries For Pain Relief From Arthritis - PR Newswire
- Emergency Med Medical News about Pain Management; Hurricane Katrina
- Physiotherapy To Help Pain Management | Natural Holistic Health Blog
- Fishbein's Doctor Sued Again - Denver Channel
- Carrying a Crystal Box: Pain Management techniques
- Monday Medical: The high cost of untreated pain - Steamboat Pilot & Today
- Local physician to offer free presentation on chronic back pain - Asheville Citizen-Times
- Orthodontic Pain Management - ChiquiBrosas.com
- DJO Incorporated Announces Date for Release of First Quarter 2009 ... - Businesswire.com
- Can we do better with postoperative pain management?
- Monday, April 27 - Daily Journal
- QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM ... - PR Newswire